# Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old

> **NCT00814762** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 41 (actual)

## Conditions studied

- AIDS

## Interventions

- **BIOLOGICAL:** HIV Vaccine 732462
- **BIOLOGICAL:** Placebo vaccine

## Key facts

- **NCT ID:** NCT00814762
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02-03
- **Primary completion:** 2010-08-18
- **Final completion:** 2010-08-18
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2018-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814762, "Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00814762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*